D-1030-2014 Class II Terminated
FDA drug recall D-1030-2014 was initiated by KVK-Tech, Inc. on Dec 11, 2013 and is designated Class II. Reason for recall: Good Manufacturing Practices Deviations: The product has an Active Pharmaceutical Ingredient from an unapproved source. The recall status is terminated (terminated Aug 3, 2015). Affected quantity: 14664 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 29, 2014
- Initiation Date
- Dec 11, 2013
- Termination Date
- Aug 3, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 14664 bottles
Product description
HydrOXYzine HCI Tablets USP 10 mg, 100 count bottles, Rx only. Mfd by KVK-TECH, INC, Newtown, PA 18940. NDC #10702-010-01.
Reason for recall
Good Manufacturing Practices Deviations: The product has an Active Pharmaceutical Ingredient from an unapproved source.
Distribution pattern
Nationwide, including Puerto Rico to wholesale distributors for sale to retail establishments.
Code information
lot #11434, exp. Nov-14
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1030-2014
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026